APOE and amyloidosis: The estimated duration of preclinical AD is approximately 10 years, but it depends on several factors including age and apolipoprotein E genotypes, while the prodromal stage with amyloid accumulation and diagnoseable mild cognitive impairment is approximately four years [19].